Cold-Stored Platelets: A Safer, Faster Option for Managing Active Bleeding and Trauma
Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, posted on LinkedIn:
”Cold-Stored Platelets (CSPs): A Practical Tool for Treating Active Bleeding
Cold-stored platelets (CSPs) are platelets stored at 1-6°C instead of the conventional room temperature (20-24°C). Growing evidence shows that CSPs better preserve immediate hemostatic function, reduce bacterial contamination risk, and offer practical advantages in hemorrhage and trauma settings when standard platelets are limited or unavailable.
Why Transfusion Services Should Pay Attention
Improved Early Hemostatic Effect
- CSPs demonstrate enhanced clot formation and stronger platelet function in vitro.
- Clinical data suggest benefit in active bleeding, especially in trauma and surgical patients.
Lower Bacterial Risk and Extended Usable Life
- Cold storage significantly limits bacterial proliferation compared to room-temperature platelets.
- Under validated protocols, CSPs may be stored for up to 14 days for specific therapeutic indications.
Targeted Clinical Use
Current evidence and guidance support CSPs mainly for treatment of active bleeding,
not for routine prophylactic platelet transfusion.
Use should align with regulatory approval, institutional policy, and transfusion-committee guidance.
Operational Notes for Blood Banks and Transfusion Laboratories
Validated SOPs Are Essential
CSPs must be stored strictly at 1-6°C.
Visual inspection for platelet aggregates or clumping is required before issue.
Dual Inventory Strategy
- Maintain both cold-stored and room-temperature platelets.
- Clearly define clinical indications for each product type.
Ongoing Monitoring and Quality Review
- Track clinical outcomes, utilization patterns, and adverse events.
- Stay updated with ongoing clinical trials and evolving regulatory recommendations.
Bottom Line
Cold-stored platelets are an evidence-based, complementary option for managing active bleeding, offering:
- Faster hemostatic response
- Reduced bacterial risk
- Operational advantages in emergency settings
However, successful use depends on careful implementation, validated procedures, and clearly defined clinical indications.”
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 04:54Saneha Anjum Shaik: What Every Clinician Should Know Before Ordering Blood Tests
-
Jul 5, 2026, 04:37Mathis Richter: How The Bone Marrow Responds To Myocardial Infarction Predicts Clinical Outcome
-
Jul 5, 2026, 02:45Marie Luise Hütter-Krönke: Can a Short Course of BCMA-Targeted Therapy Induce Long-Term Remission in Refractory Autoimmune Disease?
-
Jul 5, 2026, 02:24Shreya Agarwa: Transforming Care For Adolescents With Heavy Menstrual Bleeding
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins